Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-03-10

Clinical Trial Update: Plasma Proteomics Study of End-Stage Liver Disease Patients Based on Olink Technology

View source ↗

Summary

Clinical trial investigating plasma proteomics in end-stage liver disease using Olink technology; currently active but not recruiting, focusing on HBV-related a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: HBV Related Acute-on-chronic Liver Failure | Status: ACTIVE_NOT_RECRUITING